Surface Oncology, Inc. SURF
1.07 +1.07
Day range unavailable
52-week range unavailable
SURF revenue history
Revenue is income from the company’s ordinary business activities.
30,000,000 USD
FY 2022 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2022 | 2022-12-31 | 30,000,000 | 27,313,000 | 1016.49% |
| FY 2021 | 2021-12-31 | 2,687,000 | -123,475,000 | -97.87% |
| FY 2020 | 2020-12-31 | 126,162,000 | 110,802,000 | 721.37% |
| FY 2019 | 2019-12-31 | 15,360,000 | -44,057,000 | -74.15% |
| FY 2018 | 2018-12-31 | 59,417,000 | 46,591,000 | 363.25% |
| FY 2017 | 2017-12-31 | 12,826,000 | 6,194,000 | 93.40% |
| FY 2016 | 2016-12-31 | 6,632,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:19.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.